One year ago we first wrote about COVID-19’s impact on eating disorders – what have we learned since then?
Identifying factors associated with improved symptoms or sustained recovery can help enhance treatment and reduce relapse risk.
Our latest efforts to enhance the possibility of replication, and strengthen confidence in findings, across research studies.
Ways we are using 2020’s virtual fall conference season to make research findings more accessible.
What we know, and what our latest study is trying to learn.
A new study on how people learn from reward and loss.
What happens, and what does it mean?
Seven years after its introduction into the DSM eating disorder’s section, here is what the research on ARFID is telling us.
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins.
Written by Simon Liebling, BA. Results from a recently published large medication trial for adults with anorexia nervosa.